Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Genetically Engineered Mouse Model Reveals Key to Formation of the Blood-Brain Barrier

By LabMedica International staff writers
Posted on 05 Jul 2015
Use of a mouse model that had been genetically engineered to lack the gene that encodes the forkhead transcription factor Foxf2 has helped to explain how pericytes, cells that line the capillaries, form and maintain the blood-brain barrier.

Pericytes are critical for maturation of the brain's blood vessels and development of the blood-brain barrier, but their role in maintenance of the adult blood-brain barrier, and how central nervous system pericytes differ from those of other tissues, is less well understood. More...


Pericytes are contractile cells that wrap around the endothelial cells of capillaries throughout the body. Pericytes are embedded in basement membrane where they communicate with endothelial cells by means of both direct physical contact and paracrine signaling. In the brain, these cells are a key component of the neurovascular unit, which includes endothelial cells, astrocytes, and neurons. Pericytes help sustain the blood–brain barrier as well as several other homeostatic and hemostatic functions of the brain by regulating capillary blood flow, the clearance and phagocytosis of cellular debris, and the permeability of the blood–brain barrier. A deficiency of pericytes in the central nervous system can cause the blood–brain barrier to break down, resulting in inflammation or death of brain tissues.

Investigators at the University of Gothenburg (Sweden) recently demonstrated that the forkhead transcription factor Foxf2 was specifically expressed in pericytes of the brain and that embryos of mice genetically engineered to lack the gene for Foxf2 developed intracranial hemorrhages, perivascular edema, thinning of the vascular basal lamina, and a leaky blood-brain barrier.

FOX (Forkhead box) proteins are a family of transcription factors that play important roles in regulating the expression of genes involved in cell growth, proliferation, differentiation, and longevity. Many FOX proteins are important to embryonic development. FOX proteins also have pioneering transcription activity by being able to bind condensed chromatin during cell differentiation processes. The defining feature of FOX proteins is the forkhead box, a sequence of 80 to 100 amino acids forming a motif that binds to DNA.

"Mice that have too little or too much Foxf2 develop various types of defects in the brain's blood vessels," said senior author Dr. Peter Carlsson, professor of chemistry and molecular biology at the University of Gothenburg.

Major changes in a region of chromosome six have been associated with an increased risk of stroke, but it has not been known which of the genes in the area were responsible. "The Foxf2 gene is an extremely interesting candidate, as it is located right in the middle of this region, and research is under way now in collaboration with clinical geneticists to investigate the extent to which variations in the Foxf2 gene affect people's risk of suffering a stroke," said Dr. Carlsson.

The study was published in the June 25, 2015, online edition of the journal Developmental Cell.

Related Links:
University of Gothenburg



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Pipette Controller
Sapphire MaxiPette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.